Progressing Beyond Exploratory Endpoints: The Value of Digital Biomarkers in Neuroscience Clinical Studies Webinar Replay

Learn how advances in eCOA, digital movement analysis, and medical imaging methodologies are shaping the future of neuroscience drug development.

Digital biomarkers are revolutionizing neuroscience trials by transforming from exploratory tools into validated, impactful endpoints.

Now available on-demand:

Learn from this engaging webinar where our featured speakers present real-world examples and case studies on the strategic use of digital biomarkers. This on-demand session demonstrates how these tools improve study precision, reduce timelines, and lower sample size requirements, enhancing data quality and decision-making in psychiatric, neurological, and neurodegenerative clinical trials.

Watch this on-demand webinar to gain insights into:

• Evaluating the role of digital biomarkers in improving study efficiency and timeline management through comprehensive endpoint strategies.
• Assessing the application of wearable sensors and composite scores to advance movement disorder assessments.
• Examining vocal biomarkers such as speech latency for objective and scalable measures in psychiatric research.
• Reviewing advancements in brain imaging methodologies that contribute to the development of regulatory-ready endpoints in multiple sclerosis and related conditions.

Watch now to integrate cutting-edge digital strategies into your clinical trials for improved outcomes.